Skip to main navigation Skip to search Skip to main content

Efferocytosis fuels malignant pleural effusion through TIMP1

  • Lilan Zhao
  • , Anastasios D. Giannou
  • , Yang Xu
  • , Ahmad Mustafa Shiri
  • , Imke Liebold
  • , Babett Steglich
  • , Tanja Bedke
  • , Tao Zhang
  • , Jöran Lücke
  • , Pasquale Scognamiglio
  • , Jan Kempski
  • , Anna Woestemeier
  • , Jing Chen
  • , Theodora Agalioti
  • , Dimitra E. Zazara
  • , Diana Lindner
  • , Melanie Janning
  • , Jan K. Hennigs
  • , Rajesh M. Jagirdar
  • , Ourania S. Kotsiou
  • Sotirios G. Zarogiannis, Yasushi Kobayashi, Jacob R. Izbicki, Sourav Ghosh, Carla V. Rothlin, Lidia Bosurgi, Samuel Huber, Nicola Gagliani

Research output: Contribution to journal › Article › peer-review

Abstract

Malignant pleural effusion (MPE) results from the capacity of several human cancers to metastasize to the pleural cavity. No effective treatments are currently available, reflecting our insufficient understanding of the basic mechanisms leading to MPE progression. Here, we found that efferocytosis through the receptor tyrosine kinases AXL and MERTK led to the production of interleukin-10 (IL-10) by four distinct pleural cavity macrophage (Mφ) subpopulations characterized by different metabolic states and cell chemotaxis properties. In turn, IL-10 acts on dendritic cells (DCs) inducing the production of tissue inhibitor of metalloproteinases 1 (TIMP1). Genetic ablation of Axl and Mertk in Mφs or IL-10 receptor in DCs or Timp1 substantially reduced MPE progression. Our results delineate an inflammatory cascade—from the clearance of apoptotic cells by Mφs, to production of IL-10, to induction of TIMP1 in DCs—that facilitates MPE progression. This inflammatory cascade offers a series of therapeutic targets for MPE.

Original languageEnglish (US)
Article numbereabd6734
JournalScience Advances
Volume7
Issue number33
DOIs
StatePublished - Aug 2021
Externally publishedYes

Bibliographical note

Publisher Copyright:
Copyright © 2021 The Authors, some rights reserved.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Efferocytosis fuels malignant pleural effusion through TIMP1'. Together they form a unique fingerprint.

Cite this